Phase I trial of rosiglitazone in FSGS: I. Report of the FONT Study Group.
Joy MS, Gipson DS, Dike M, Powell L, Thompson A, Vento S, Eddy A, Fogo AB, Kopp JB, Cattran D, Trachtman H.
Clin J Am Soc Nephrol. 2009 Jan;4(1):39-47. Epub 2008 Dec 10.PMID: 19073787 [PubMed - indexed for MEDLINE]Related articles